Precision BioSciences, Inc. operates as a genome editing company and develops therapeutic products primarily in the United States. The company offers ARCUS, a genome editing platform to cure cancers and genetic disorders. Precision BioSciences Inc. is based in Durham, North Carolina.
Info & Links
CEO
Michael Amoroso
Headquarters
302 EAST PETTIGREW STREET,SUITE A-100 DURHAM, NC 27701, UNITED STATES
Precision BioSciences, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
42.63M
Enterprise Value
-33.85M
Enterprise Value/EBITDA(ttm)
2.93
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
0.60
Price to Book(mrq)
0.66
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
100.00%
Operating Margin(ttm)
-15.43%
Profit Margin(ttm)
-742.13%
Return on Equity(ttm)
-23.69%
Return on Invested Capital(ttm)
-23.16%
Return on Assets(ttm)
-6.98%
Income Statement
Revenue(ttm)
75.10M
Revenue Per Share(ttm)
9.79
Gross Profit(ttm)
75.10M
EBITDA(ttm)3
-11.54M
Net Income Available to Common(ttm)
8.62M
Diluted EPS(ttm)
0.06
Share Statistics
Beta (5Y Monthly)
1.51
52-Week Change
-58.19%
S&P 500 52-Week Change
18.40%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
7.67M
Dividend Yield
0.00%
Float4
7.36M
% Held by Insiders
4.00%
% Held by Institutions
37.99%
Balance Sheet
Total Cash(mrq)
101.20M
Total Cash Per Share(mrq)
13.19
Total Debt(mrq)
22.28M
Total Debt/Equity(mrq)
34.34%
Current Ratio(mrq)
9.22%
Quick Ratio(mrq)
9.22%
Book Value Per Share(mrq)
8.67
Cash Flow
Operating Cash Flow Per Share(ytd)
-5.46
Free Cash Flow(ytd)
-39.85M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.